A Prospective Randomized Trial on Mycophenolate Mofetil in Risk Penetrating Keratoplasty

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Corneal Transplantation
Interventions
DRUG

Mycophenolate Mofetil 2x 1g

Trial Locations (1)

79106

University Eye hospital, Freiburg im Breisgau

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

University Hospital Freiburg

OTHER